Cytidine Deaminase Enzymatic Activity Is a Prognostic Biomarker in Gemcitabine/Platinum-Treated Advanced Non-Small-Cell Lung Cancer: A Prospective Validation Study
British Journal of Cancer - United Kingdom
doi 10.1038/s41416-018-0307-3
Full Text
Open PDFAbstract
Available in full text
Date
November 1, 2018
Authors
Publisher
Springer Science and Business Media LLC